Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder
ir.definiumtx.com/news-events/press-releases/...
ir.definiumtx.comPosted Aug 12, 2026, 11:03 AM UTC
539
ir.definiumtx.comLoading comments…